Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP

Last updated on 2025-03-03 History
Report ID 189373
Drug Identification Number 02433443
Brand name JAMP-NYSTATIN ORAL SUSPENSION USP
Common or Proper name Nystatin Oral Suspension USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) NYSTATIN
Strength(s) 100000UNIT
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 500
ATC code A07AA
ATC description INTESTINALANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-12
Estimated end date 2025-05-31
Actual end date
Shortage status Actual shortage
Updated date 2025-03-03
Company comments Format 100 available. Under allocation
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2025-03-03 French Compare
v34 2025-03-03 English Compare
v33 2025-01-04 French Compare
v32 2025-01-04 English Compare
v31 2024-11-01 French Compare
v30 2024-11-01 English Compare
v29 2024-11-01 French Compare
v28 2024-11-01 English Compare
v27 2024-09-04 French Compare
v26 2024-09-04 English Compare
v25 2024-07-29 French Compare
v24 2024-07-29 English Compare
v23 2024-07-03 French Compare
v22 2024-07-03 English Compare
v21 2024-03-11 French Compare
v20 2024-03-11 English Compare
v19 2024-03-04 French Compare
v18 2024-03-04 English Compare
v17 2023-12-18 French Compare
v16 2023-12-18 English Compare

Showing 1 to 20 of 35